Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

In-Jin Jang

Showing results (41-50 of 292) with videos related to

Pageof 30
Sort By:
Translational and Clinical Pharmacology|February 26, 2020
Pharmacokinetic comparison between fixed-dose combination of fimasartan/amlodipine 60/10 mg and the corresponding loose combination through partial replicated crossover study in healthy subjectsEunsol Yang, Soyoung Lee, Heechan Lee, et al.
Journal of Clinical Medicine|February 13, 2019
A Personalized CYP2C19 Phenotype-Guided Dosing Regimen of Voriconazole Using a Population Pharmacokinetic AnalysisYun Kim, Su-Jin Rhee, Wan Beom Park, et al.
Translational and Clinical Pharmacology|April 15, 2021
Pharmacokinetic comparison between a fixed-dose combination of fimasartan/amlodipine/hydrochlorothiazide 60/10/25 mg and a corresponding loose combination of fimasartan/amlodipine 60/25 mg and hydrochlorothiazide 25 mg in healthy subjectsJihyun Jung, Soyoung Lee, Jaeseong Oh, et al.
Drug Design, Development and Therapy|November 22, 2017
Pharmacokinetics and tolerability of MB12066, a beta-lapachone derivative targeting NAD(P)H: quinone oxidoreductase 1: two independent, double-blind, placebo-controlled, combined single and multiple ascending dose first-in-human clinical trialsSeokuee Kim, SeungHwan Lee, Joo-Youn Cho, et al.
Drug Design, Development and Therapy|May 12, 2018
Pharmacokinetic characteristics of telaprevir in healthy Korean male subjects and comparisons with JapaneseYewon Choi, Seonghae Yoon, Kyoko Matsumoto, et al.
Expert Opinion on Drug Safety|June 9, 2016
An analysis of QTc prolongation with atypical antipsychotic medications and selective serotonin reuptake inhibitors using a large ECG record databaseSang-In Park, Hyungmi An, Anhye Kim, et al.
Expert Opinion on Investigational Drugs|August 22, 2024
Pharmacokinetics, pharmacodynamics, safety, and tolerability of a single-dose riliprubart, an anti-C1s humanized monoclonal antibody in East-Asian adults: results from a Phase 1, randomized, open-label trialYingxin Li, Joo Young Na, Yunting Zhu, et al.
Clinical Therapeutics|March 1, 2011
Relative bioavailability and tolerability of two formulations of bicalutamide 50-mg tablets: a randomized-sequence, open-label, two-period crossover study in healthy Korean male subjectsSeunghwan Lee, Seo Hyun Yoon, Joo-Youn Cho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2007
Clinical implications of CYP2D6 genotypes predictive of tamoxifen pharmacokinetics in metastatic breast cancerHyeong-Seok Lim, Han Ju Lee, Keun Seok Lee, et al.
Translational and Clinical Pharmacology|March 6, 2020
Pharmacokinetic characteristics of fluticasone, salmeterol and tiotropium after concurrent inhalationJung Sunwoo, Su-Jin Rhee, SeungHwan Lee, et al.
Pageof 30

Showing results (41-50 of 292) with videos related to

Sort By:
Pageof 30
Translational and Clinical Pharmacology|February 26, 2020
Pharmacokinetic comparison between fixed-dose combination of fimasartan/amlodipine 60/10 mg and the corresponding loose combination through partial replicated crossover study in healthy subjectsEunsol Yang, Soyoung Lee, Heechan Lee, et al.
Journal of Clinical Medicine|February 13, 2019
A Personalized CYP2C19 Phenotype-Guided Dosing Regimen of Voriconazole Using a Population Pharmacokinetic AnalysisYun Kim, Su-Jin Rhee, Wan Beom Park, et al.
Translational and Clinical Pharmacology|April 15, 2021
Pharmacokinetic comparison between a fixed-dose combination of fimasartan/amlodipine/hydrochlorothiazide 60/10/25 mg and a corresponding loose combination of fimasartan/amlodipine 60/25 mg and hydrochlorothiazide 25 mg in healthy subjectsJihyun Jung, Soyoung Lee, Jaeseong Oh, et al.
Drug Design, Development and Therapy|November 22, 2017
Pharmacokinetics and tolerability of MB12066, a beta-lapachone derivative targeting NAD(P)H: quinone oxidoreductase 1: two independent, double-blind, placebo-controlled, combined single and multiple ascending dose first-in-human clinical trialsSeokuee Kim, SeungHwan Lee, Joo-Youn Cho, et al.
Drug Design, Development and Therapy|May 12, 2018
Pharmacokinetic characteristics of telaprevir in healthy Korean male subjects and comparisons with JapaneseYewon Choi, Seonghae Yoon, Kyoko Matsumoto, et al.
Expert Opinion on Drug Safety|June 9, 2016
An analysis of QTc prolongation with atypical antipsychotic medications and selective serotonin reuptake inhibitors using a large ECG record databaseSang-In Park, Hyungmi An, Anhye Kim, et al.
Expert Opinion on Investigational Drugs|August 22, 2024
Pharmacokinetics, pharmacodynamics, safety, and tolerability of a single-dose riliprubart, an anti-C1s humanized monoclonal antibody in East-Asian adults: results from a Phase 1, randomized, open-label trialYingxin Li, Joo Young Na, Yunting Zhu, et al.
Clinical Therapeutics|March 1, 2011
Relative bioavailability and tolerability of two formulations of bicalutamide 50-mg tablets: a randomized-sequence, open-label, two-period crossover study in healthy Korean male subjectsSeunghwan Lee, Seo Hyun Yoon, Joo-Youn Cho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2007
Clinical implications of CYP2D6 genotypes predictive of tamoxifen pharmacokinetics in metastatic breast cancerHyeong-Seok Lim, Han Ju Lee, Keun Seok Lee, et al.
Translational and Clinical Pharmacology|March 6, 2020
Pharmacokinetic characteristics of fluticasone, salmeterol and tiotropium after concurrent inhalationJung Sunwoo, Su-Jin Rhee, SeungHwan Lee, et al.
Pageof 30